These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16136486)

  • 1. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE).
    Bosco C; Parra M; Barja P; Rodrigo R; Fernández V; Suarez M; Muñoz H
    Histol Histopathol; 2005 Oct; 20(4):1045-55. PubMed ID: 16136486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
    Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
    Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of thrombomodulin and plasminogen activator inhibitor type-I in pregnancy induced hypertension and its clinical significance.
    Ma S; Bai C; Bian X
    Chin Med Sci J; 2001 Sep; 16(3):169-71. PubMed ID: 12899332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered release of thrombomodulin and HMGB1 in the placenta complicated with preeclampsia.
    Oda H; Nagamatsu T; Iriyama T; Osuga Y
    Placenta; 2024 Mar; 148():12-19. PubMed ID: 38330539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia.
    Shaarawy M; Didy HE
    Int J Gynaecol Obstet; 1996 Nov; 55(2):135-9. PubMed ID: 8960994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
    Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
    Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].
    Ma S; Bai C; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):712-4. PubMed ID: 11479955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
    Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased endothelial thrombomodulin (TM) expression in pregnancies complicated by IUGR.
    Wienhard J; Bielska B; Münstedt K; Lang U; Zygmunt M
    J Perinat Med; 2002; 30(4):322-8. PubMed ID: 12235721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
    Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
    Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.
    He S; Bremme K; Blombäck M
    Blood Coagul Fibrinolysis; 1995 Dec; 6(8):703-8. PubMed ID: 8825219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A; Kobayashi T; Terao T
    Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of thrombomodulin in maternal plasma and placental tissue in early onset severe preeclampsia].
    Zhu J; Li L; Li M; He M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):752-6. PubMed ID: 26675574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental thromboinflammation impairs embryonic survival by reducing placental thrombomodulin expression.
    Kohli S; Singh KK; Gupta A; Markmeyer P; Lochmann F; Gupta D; Rana R; Elwakiel A; Huebner H; Ruebner M; Isermann B
    Blood; 2021 Feb; 137(7):977-982. PubMed ID: 32870264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia.
    Alpoim PN; Perucci LO; Godoi LC; Goulart COL; Dusse LMS
    Clin Chim Acta; 2018 Aug; 483():234-238. PubMed ID: 29723511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
    Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
    Sartori MT; Serena A; Saggiorato G; Campei S; Faggian D; Pagnan A; Paternoster DM
    J Thromb Haemost; 2008 Feb; 6(2):352-8. PubMed ID: 18021302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia?
    Dusse LM; Alpoim PN; Lwaleed BA; de Sousa LP; Carvalho Md; Gomes KB
    Clin Chim Acta; 2013 Jan; 415():226-9. PubMed ID: 23089074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.
    Parra-Cordero M; Bosco C; González J; Gutiérrez R; Barja P; Rodrigo R
    J Mol Histol; 2011 Oct; 42(5):459-65. PubMed ID: 21847508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.